Partnering with Big Pharma-What Academics Need to Know.
Knowledge of the parameters of drug development can greatly aid academic scientists hoping to partner with pharmaceutical companies. Here, we discuss the three major pillars of drug development-pharmacodynamics, pharmacokinetics, and toxicity studies-which, in addition to pre-clinical efficacy, are critical for partnering with Big Pharma to produce novel therapeutics.
Scintillon Institute, San Diego, CA 92121, USA; The Scripps Research Institute, La Jolla, CA 92037, USA; School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: slipton@ucsd.edu.
Stuart A
SA
Lipton
Eli Lilly and Company, Indianapolis, IN 46285, USA.
Christer
C
Nordstedt
D000818:Animals; D002986:Clinical Trials as Topic; D016503:Drug Delivery Systems; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D006801:Humans; D010599:Pharmacokinetics; D014495:Universities